DK2408446T3 - Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon - Google Patents
Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon Download PDFInfo
- Publication number
- DK2408446T3 DK2408446T3 DK10710448T DK10710448T DK2408446T3 DK 2408446 T3 DK2408446 T3 DK 2408446T3 DK 10710448 T DK10710448 T DK 10710448T DK 10710448 T DK10710448 T DK 10710448T DK 2408446 T3 DK2408446 T3 DK 2408446T3
- Authority
- DK
- Denmark
- Prior art keywords
- mesembrenone
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- containing mesembrenone
- Prior art date
Links
- HDNHBCSWFYFPAN-IRXDYDNUSA-N Mesembrenone Chemical compound C1=C(OC)C(OC)=CC=C1[C@@]1(C=CC(=O)C2)[C@H]2N(C)CC1 HDNHBCSWFYFPAN-IRXDYDNUSA-N 0.000 title 1
- HDNHBCSWFYFPAN-UHFFFAOYSA-N mesembrenone Natural products C1=C(OC)C(OC)=CC=C1C1(C=CC(=O)C2)C2N(C)CC1 HDNHBCSWFYFPAN-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Heart & Thoracic Surgery (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200902003 | 2009-03-20 | ||
| PCT/IB2010/051132 WO2010106494A1 (en) | 2009-03-20 | 2010-03-16 | Use of pharmaceutical compositions containing mesembrenone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2408446T3 true DK2408446T3 (da) | 2019-12-09 |
Family
ID=42167479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10710448T DK2408446T3 (da) | 2009-03-20 | 2010-03-16 | Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8552051B2 (da) |
| EP (1) | EP2408446B1 (da) |
| AU (1) | AU2010224485B2 (da) |
| DK (1) | DK2408446T3 (da) |
| ES (1) | ES2759675T3 (da) |
| PL (1) | PL2408446T3 (da) |
| PT (1) | PT2408446T (da) |
| WO (1) | WO2010106494A1 (da) |
| ZA (1) | ZA201106703B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010224486B2 (en) | 2009-03-20 | 2014-04-24 | Hg&H Pharmaceuticals (Pty) Ltd | Sceletium extract and uses thereof |
| GB201101075D0 (en) | 2011-01-21 | 2011-03-09 | Labminds Ltd | Automated solution dispenser |
| CA2826183C (en) * | 2011-02-07 | 2019-05-14 | Scipharm Sarl | Novel composition for the treatment of cystic fibrosis |
| KR20150119370A (ko) | 2013-02-19 | 2015-10-23 | 화이자 인코포레이티드 | Cns 장애 및 다른 장애의 치료를 위한 pde4 동종효소의 억제제로서의 아자벤즈이미다졸 화합물 |
| CA2925318C (en) | 2013-09-27 | 2021-01-19 | Justin SHER | Nutraceutical composition for pde4 inhibition, enhanced dopamine metabolism and long term potentiation |
| US20170065653A1 (en) | 2014-02-28 | 2017-03-09 | Nature's Sunshine Products, Inc. | Phosphodiesterase Inhibiting Phytochemical Compositions |
| EP3172210B1 (en) | 2014-07-24 | 2020-01-15 | Pfizer Inc | Pyrazolopyrimidine compounds |
| WO2016020786A1 (en) | 2014-08-06 | 2016-02-11 | Pfizer Inc. | Imidazopyridazine compounds |
| JP2018507103A (ja) | 2015-02-06 | 2018-03-15 | ラブマインズ リミテッド | 自動化溶液ディスペンサ |
| WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
| WO2019021196A1 (en) | 2017-07-26 | 2019-01-31 | Hg&H Pharmaceuticals (Pty) Ltd | MESEMBRENOL AND / OR MESEMBRANOL FOR THE PROPHYLAXIS AND TREATMENT OF PATIENTS SUFFERING FROM EPILEPSY AND RELATED DISEASES |
| WO2021086345A1 (en) * | 2019-10-30 | 2021-05-06 | Plant Synergy Inc. | High yield extraction method for and products of kanna plants |
| US10864239B1 (en) | 2019-10-30 | 2020-12-15 | Plant Synergy Inc. | High yield extraction method for and products of kanna plants |
| US20250051277A1 (en) | 2021-10-29 | 2025-02-13 | Sensorium Therapeutics, Inc. | Delivery of therapeutic alkaloid compounds |
| US12410128B1 (en) | 2022-04-15 | 2025-09-09 | Sensorium Therapeutics, Inc. | Therapeutic alkaloid compounds |
| AU2023440404A1 (en) * | 2023-03-28 | 2025-11-06 | Stellenbosch University | Composition comprising a sceletium extract and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3604112A1 (de) | 1986-02-10 | 1987-08-13 | Bernhard Dr Janiak | Pflanzenextrakte von mesembryanthemaceen sowie solche enthaltende schaedlingsbekaempfungsmittel und arzneimittel |
| US6271001B1 (en) | 1995-03-23 | 2001-08-07 | Bio Polymers Pty. Ltd. | Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications |
| ZA974576B (en) * | 1996-06-04 | 1998-02-04 | Farmarc Nederland Bv | Pharmaceutical composition. |
| SE9804064D0 (sv) | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| EP1257560A4 (en) | 2000-02-01 | 2003-10-01 | Human Genome Sciences Inc | BCL-2 SIMILAR POLYNUCLEOTIDES, POLYPEPTIDES AND ANTIBODIES |
| GB0111579D0 (en) * | 2001-05-11 | 2001-07-04 | Holford & Associates Ltd | Oral supplement |
| EP1572099A4 (en) | 2002-10-04 | 2007-01-03 | Univ California | SCREENING AND THERAPEUTIC METHODS RELATED TO THE NEUROGENESIS |
| US6969702B2 (en) | 2002-11-20 | 2005-11-29 | Neuronova Ab | Compounds and methods for increasing neurogenesis |
| DK1583541T3 (da) | 2002-11-20 | 2011-04-11 | Neuronova Ab | Forbindelser og fremgangsmåder til at øge neurogenese |
| AU2003293409A1 (en) | 2002-12-09 | 2004-06-30 | Karl K. Johe | Method for discovering neurogenic agents |
| WO2004093802A2 (en) | 2003-04-17 | 2004-11-04 | The Board Of Trustees Of The Leland Stanford Junior University | Prevention of deficits in neurogenesis with anti-inflammatory agents |
| US7763588B2 (en) | 2003-06-13 | 2010-07-27 | The Salk Institute For Biological Studies | Method for increasing cognitive function and neurogenesis |
| JP2007519393A (ja) | 2003-08-05 | 2007-07-19 | ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． | 神経系細胞アッセイ |
| EP1771435A4 (en) * | 2004-06-19 | 2008-02-13 | Human Biomolecular Res Inst | MODULATORS OF NEUROTRANSMITTERS OF THE CENTRAL NERVOUS SYSTEM |
| AU2010224486B2 (en) | 2009-03-20 | 2014-04-24 | Hg&H Pharmaceuticals (Pty) Ltd | Sceletium extract and uses thereof |
-
2010
- 2010-03-16 PL PL10710448T patent/PL2408446T3/pl unknown
- 2010-03-16 US US13/256,686 patent/US8552051B2/en active Active
- 2010-03-16 AU AU2010224485A patent/AU2010224485B2/en active Active
- 2010-03-16 DK DK10710448T patent/DK2408446T3/da active
- 2010-03-16 EP EP10710448.1A patent/EP2408446B1/en active Active
- 2010-03-16 WO PCT/IB2010/051132 patent/WO2010106494A1/en not_active Ceased
- 2010-03-16 ES ES10710448T patent/ES2759675T3/es active Active
- 2010-03-16 PT PT107104481T patent/PT2408446T/pt unknown
-
2011
- 2011-09-13 ZA ZA2011/06703A patent/ZA201106703B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL2408446T3 (pl) | 2020-03-31 |
| ES2759675T3 (es) | 2020-05-11 |
| WO2010106494A1 (en) | 2010-09-23 |
| US8552051B2 (en) | 2013-10-08 |
| AU2010224485B2 (en) | 2014-04-17 |
| AU2010224485A1 (en) | 2011-10-20 |
| EP2408446B1 (en) | 2019-09-11 |
| EP2408446A1 (en) | 2012-01-25 |
| PT2408446T (pt) | 2019-12-18 |
| ZA201106703B (en) | 2012-05-30 |
| US20120041045A1 (en) | 2012-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2408446T3 (da) | Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon | |
| DK2498756T3 (da) | Tabletformuleringer af neratinibmaleat | |
| SMT201600350B (it) | Composizioni farmaceutiche | |
| DK3156056T3 (da) | Farmaceutiske sammensætninger der består af sorbitanestere | |
| SMT201700008B (it) | Composizione farmaceutica | |
| DK3685835T3 (da) | Farmaceutiske sammensætninger, der omfatter derivater af perillylalkohol | |
| LT3061445T (lt) | Labai koncentruotos farmacinės kompozicijos | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| BRPI1012539A2 (pt) | composições farmacêuticas | |
| LT3222272T (lt) | Farmacinė karbetocino kompozicija | |
| PT2593094T (pt) | Composição aquosa contendo bromexina | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| DOP2011000396A (es) | Composiciones novedosas | |
| BR112012003263A2 (pt) | formulações intravenosas de antagonistas de neuroquinina-1 | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| DK2654736T3 (da) | Hidtil ukendt farmaceutisk sammensætning | |
| DK2419096T3 (da) | Stabilisering af radiofarmaceutiske sammensætninger under anvendelse af ascorbinsyre | |
| DK2403512T3 (da) | Sammensætninger af polymer myrcen | |
| LT2966175T (lt) | Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato | |
| IT1394400B1 (it) | Composizioni farmaceutiche | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| PL2393476T3 (pl) | Kompozycje resweratrolu | |
| EE201300005A (et) | Ravimkoostis | |
| DK2405972T3 (da) | Anvendelse af rosuvastatin lactoler som medikamenter |